Wheat Obiwan

Austrian Breeding for Consistent Yields

The winter wheat variety "Obivan" from RWA (Raiffeisen Ware Austria) reflects the company's commitment to high-intensity agriculture. As a soft wheat variety, it is engineered for farmers who prioritize plant health and reliability in variable climates. Its pedigree, rooted in Austrian research, ensures it meets the high standards required for commercial wheat production.

Biological Potential and Key Metrics

Standing at a height of 60–70 cm, Obivan falls into the short-straw category, which is an advantage during harvest operations, reducing lodging-related losses. While the variety exhibits moderate resistance to lodging, its overall growth habit allows for effective management using standard growth regulation practices.

Key productivity and grain quality data:

• Potential yield: 7–8 tonnes per hectare.
• Thousand Kernel Weight (TKW): 45–50 grams.
• Gluten content: 20–25%.

Pathogen Resistance and Field Performance

One of the primary benefits of selecting Obivan is its comprehensive resistance to common wheat diseases. In regions prone to high humidity, where fungal threats can decimate yields, Obivan provides a stable buffer, showing strong resistance against:

• Brown rust;
• Septoria;
• Fusarium head blight;
• Powdery mildew.

This genetic profile helps agronomists optimize fungicide programs, potentially reducing chemical reliance while maintaining crop health. Obivan is designed for operations utilizing intensive cultivation techniques where high-quality grain and consistent head health are essential for market success.

By leveraging Austrian agricultural expertise, Obivan provides a reliable solution for producers seeking a robust variety that balances yield potential with the resilience needed to combat modern agricultural challenges.